Amisulpride in the treatment of somatoform disorders.

摘要

The central notion of somatoform disorders (SFDs) are the presence of physical symptoms that are 'medically unexplained' or 'disproportionate' to the severity of an underlying medical disorder, thereby giving rise to the belief that psychological therapy rather than pharma-cotherapy be considered as first line management [1]. However, pharmaceutical agents such as Tricyclic anti-depressants (TCAs), Selective Serotonin Reuptake Inhibitors (SSRIs) and recently substituted benzamides have been used selectively for the treatment of a variety of SFDs [2]. We report three patients with various presentations of SFDs where the use of low dose amisulpride, another substituted benzamide, proved beneficial.